Original site: www.cdc.gov/niosh-rtecs/MO1A8CE0.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Comparison timestamp: 2025-05-03 08:31:22 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/niosh-rtecs/MO1A8CE0.html
Live cdc.gov URL ↗: https://www.cdc.gov/niosh-rtecs/MO1A8CE0.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/niosh-rtecs/MO1A8CE0.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to page options
The National Institute for Occupational Safety and Health (NIOSH)
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Search
Search Menu Navigation Menu
× NIOSH
NIOSH All CDC
Submit
* Licensing Agreement Signed for RTECS
* How Do I Access the RTECS Database?
* Features of the RTECS Database
* The National Institute for Occupational Safety and Health (NIOSH) Home
The National Institute for Occupational Safety and Health (NIOSH)
1. Registry of Toxic Effects of Chemical Substances (RTECS)
Hexane, 1,6-diisocyanato-
Related Pages
RTECS #
MO1740000
CAS #
822-06-0; 66368-96-5
See: NMAM or OSHA Methods
Updated
December 2018
Molecular Weight
168.22
Molecular Formula
C8H12N2O2
Synonyms
1,6-Diisocyanatohexane
1,6-Hexamethylene diisocyanate
1,6-Hexanediol diisocyanate
Desmodur H
Desmodur N
HDI
HDI-IC
Hexamethylendiisokyanat (Czech)
Hexamethylene diisocyanate
Hexamethylene diisocyanate (ACGIH)
Hexamethylene-1,6-diisocyanate
HMDI
Isocyanic acid, diester with 1,6-hexanediol
Isocyanic acid, hexamethylene ester
Metyleno-bis-fenyloizocyjanian (Polish)
Szesciometylenodwuizocyjanian (Polish)
TL 78
Acute Toxicity Data and References
Route/Organism Dose Effect Reference
In Vitro/Human, lung Inhibitor Concentration (20 percent kill): 1.1 mmol/L In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. TIVIEQ 30,274,2015
In Vitro/Human, lung fibroblast Inhibitor Concentration Low: 95 µmol/L/6H In Vitro Toxicity Studies: Other assays TIVIEQ 28,209,2014
In Vitro/Human, skin Inhibitor Concentration (20 percent kill): 40 mg/L/24H In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. TIVIEQ 27,1127,2013
inhalation/mouse lethal concentration (50 percent kill): 30 mg/m3 85GMAT -,74,1982
Eye: Lacrimation
inhalation/rat Lowest published lethal concentration: 60 mg/m3/4H Lung, Thorax, or Respiration: Dyspnea GTPZAB 12(10),40,1968
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
inhalation/rat lethal concentration (50 percent kill): 124 mg/m3/4H TOSCF2 58,173,2000
Lung, Thorax, or Respiration: Changes in lung weight
inhalation/rat lethal concentration (50 percent kill): 462 mg/m3/4H TOSCF2 58,173,2000
Biochemical: Metabolism (intermediary): Other proteins
Lung, Thorax, or Respiration: Other changes
inhalation/rat lowest published toxic concentration: 15.9 mg/m3/6H TOSCF2 58,173,2000
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
Lung, Thorax, or Respiration: Consolidation
inhalation/rat lowest published toxic concentration: 54.3 mg/m3/6H Lung, Thorax, or Respiration: Acute pulmonary edema TOSCF2 58,173,2000
Lung, Thorax, or Respiration: Pleural effusion
inhalation/rat lowest published toxic concentration: 118.1 mg/m3/6H TOSCF2 58,173,2000
intravenous/mouse lethal dose (50 percent kill): 5600 µg/kg CSLNX* NX#07805
oral/mouse lethal dose (50 percent kill): 350 mg/kg TAKHAA 39,202,1980
oral/rat lethal dose (50 percent kill): 710 µL/kg AIHAAP 30,470,1969
skin/rabbit lethal dose (50 percent kill): 570 µL/kg AIHAAP 30,470,1969
Other Multiple Dose Data and References
Route/Organism Dose Effect Reference
inhalation/guinea pig lowest published toxic concentration: 1 ppm/6H/5D- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field NTIS** OTS0571057
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
inhalation/mouse lowest published toxic concentration: 300 ppb/6H/5D- intermittent NTIS** OTS0571057
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
Immunological Including Allergic: Increased immune response
inhalation/mouse lowest published toxic concentration: 7.5 mg/m3/3D- intermittent Biochemical: Metabolism (intermediary): Other proteins TXCYAC 261,103,2009
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
inhalation/rat lowest published toxic concentration: 0.05 ppm/6H/28D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000
inhalation/rat lowest published toxic concentration: 0.05 ppm/6H/47D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000
inhalation/rat lowest published toxic concentration: 0.05 ppm/20D- continuous Olfaction: Other olfaction effects TJADAB 162,205,2000
inhalation/rat lowest published toxic concentration: 50 ppb/6H/30D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000
inhalation/rat lowest published toxic concentration: 2 ppm/6H/5D- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field NTIS** OTS0571057
Olfaction: Other olfaction effects
inhalation/rat lowest published toxic concentration: 40 ppb/6H/13W- intermittent NTIS** OTS0532755
Eye: Conjunctiva irritation
Behavioral: Convulsions or effect on seizure threshold
inhalation/rat lowest published toxic concentration: 30 ppm/4H/2W- intermittent Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi NTIS** OTS0555659
Lung, Thorax, or Respiration: Dyspnea
Gastrointestinal: Changes in structure or function of salivary glands
oral/rat lowest published toxic dose: 3 gm/kg/2W- intermittent Gastrointestinal: Hypermotility, diarrhea NTIS** OTS0555659
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
Immunological Including Allergic: Increased immune response
skin/mouse lowest published toxic dose: 1 pph/3D- intermittent Biochemical: Metabolism (intermediary): Other proteins TXCYAC 261,103,2009
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
Reviews
Organization Standard Reference
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value-time-weighted average 0.005 ppm DTLVS* TLV/BEI,2013
TOXICOLOGY REVIEW TOLED5 140-141,213,2003
TOXICOLOGY REVIEW FCTOD7 55,596,2013
TOXICOLOGY REVIEW RTOPDW 55,43,2009
Standards and Regulations
Organization Standard Reference
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV;
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV
Occupational Exposure Limit-AUSTRALIA time-weighted average 0.02 mg(NCO)/m3, short term exposure limit 0.07 mg(NCO)/m3, JUL2008
Occupational Exposure Limit-AUSTRIA MAK-TMW 0.005 ppm (0.035 mg/m3);KZW 0.005 ppm (0.035 mg/m3), sen, 2007
Occupational Exposure Limit-BELGIUM time-weighted average 0.005 ppm (0.034 mg/m3), MAR2002
Occupational Exposure Limit-DENMARK time-weighted average 0.005 ppm (0.035 mg/m3), MAY2011
Occupational Exposure Limit-FRANCE VME 0.01 ppm (0.075 mg/m3), VLE 0.02 ppm (0.15 mg/m3), FEB2006
Occupational Exposure Limit-GERMANY MAK 0.005 ppm (0.035 mg/m3), 2011
Occupational Exposure Limit-HUNGARY time-weighted average 0.035 mg/m3, short term exposure limit 0.035 mg/m3, SEP2000
Occupational Exposure Limit-ICELAND time-weighted average 0.005 ppm (0.03 mg/m3), short term exposure limit 0.01 ppm (0.07 mg/m3), sen, NOV2011
Occupational Exposure Limit-JAPAN Occupational Exposure Limit 0.005 ppm (0.034 mg/m3), a1 sen, MAY2012
Occupational Exposure Limit-NEW ZEALAND time-weighted average 0.02 mg(NCO)/m3; short term exposure limit 0.07 mg(NCO)/m3, sen, JAN2002
Occupational Exposure Limit-PERU time-weighted average 0,005 ppm (0,034 mg/m3), JUL2005
Occupational Exposure Limit-POLAND MAC(time-weighted average) 0.05 mg/m3, short term exposure limit 0.15 mg/m3, JAN1999
Occupational Exposure Limit-RUSSIA short term exposure limit 0.05 mg/m3, Skin, JUN2003
Occupational Exposure Limit-SWEDEN time-weighted average 0.002 ppm (0.02 mg/m3), ceiling concentration 0.005 ppm (0.03 mg/m3), Sen, JUN2005
Occupational Exposure Limit-SWITZERLAND ceiling concentration 0.02 mg(NCO)/m3, skin, sen, JAN2011
Occupational Exposure Limit-THE NETHERLANDS MAC-TGG 0.04 mg/m3, 2003
NIOSH Documentation and Surveillance
Organization Standard Reference
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HDI-air 10H time-weighted average 0.035 mg/m3;ceiling concentration 0.14 mg/m3/10M NIOSH* DHHS #92-100,1992
National Occupational Exposure Survey 1983 Hazard Code M4839; Number of Industries 21; Total Number of Facilities 1895; Number of Occupations 26; Total Number of Employees Exposed 19180; Total Number of Female Employees Exposed 329
National Occupational Hazard Survey 1974 Hazard Code M4839; Number of Industries 9; Total Number of Facilities 238; Number of Occupations 12; Total Number of Employees Exposed 4490
Status in Federal Agencies
Organization Reference
ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/102543/AS)
EPA TSCA Section 8(b) CHEMICAL INVENTORY
EPA TSCA Section 8(d) unpublished health/safety studies
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
NIOSH Analytical Method, 1994: Isocyanates, monomeric, 5521
NIOSH Analytical Method, 1996: Isocyanates, 5522
On EPA IRIS database
OSHA ANALYTICAL METHOD #42
Page last reviewed: November 16, 2018
Content source: National Institute for Occupational Safety and Health
* Facebook
* Twitter
* LinkedIn
* Syndicate
Registry of Toxic Effects of Chemical Substances (RTECS)
* Licensing Agreement Signed for RTECS
* How Do I Access the RTECS Database?
* Features of the RTECS Database
Follow NIOSH
* Facebook
* Pinterest
* Twitter
* YouTube
NIOSH Homepage
* Workplace Safety & Health Topics
* Publications and Products
* Programs
* Contact NIOSH
* About CDC
* Contact Us
* 800-232-4636
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS
* CONTACT CDC
Contact Us
Call 800-232-4636
Email Us
* ABOUT CDC
+ About CDC
+ Jobs
+ Funding
* POLICIES
+ Accessibility
+ External Links
+ Privacy
+ Policies
+ Web Policies
+ No Fear Act
+ FOIA
+ OIG
+ No Fear Act
+ Nondiscrimination
+ Vulnerability Disclosure Policy
+ CDC Archive
+ Public Health Publications
+ HHS.gov
+ USA.gov
* CONNECT WITH US
+ Facebook
+ Twitter
+ Instagram
+ LinkedIn
+ Youtube
+ Pinterest
+ Snapchat
+ Email
* LANGUAGES
+ Español
+ 繁體中文
+ Tiếng Việt
+ 한국어
+ Tagalog
+ Русский
+ العربية
+ Kreyòl Ayisyen
+ Français
+ Polski
+ Português
+ Italiano
+ Deutsch
+ 日本語
+ فارسی
+ English
* U.S. Department of Health & Human Services
* Accessibility
* External Links
* Privacy
* Policies
* Web Policies
* FOIA
* OIG
* No Fear Act
* FOIA
* Nondiscrimination
* OIG
* Vulnerability Disclosure Policy
* CDC Archive
* Public Health Publications
* HHS.gov
* USA.gov
Content Credential
×
This image was edited or created using GenAI (generative artificial intelligence).
Our experts review all images in an effort to ensure accuracy and quality before use.
Learn more about CDC's usage of GenAI.
Exit Notification/Disclaimer Policy
Close
Links with this icon indicate that you are leaving the CDC website.
* The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
* Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
* You will be subject to the destination website's privacy policy when you follow the link.
* CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
Cancel Continue
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.